Avantax Advisory Services’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
Avantax Advisory Services's BIIB Position: Q2 2025 in Review
Avantax Advisory Services opened a new position in Biogen (BIIB) in Q2 2025: 2,498 shares worth $314K. The stake represents ﹤0.01% of the portfolio and ranks #1875 among its holdings. This is a return to the name: Avantax Advisory Services previously reported a position in BIIB as recently as Q2 2024.
Avantax Advisory Services first reported a position in BIIB in Q1 2020 and has held it in 13 quarters since. The position peaked at $617K in Q3 2021. 866 funds tracked by Wall St. Rank hold BIIB as of Q2 2025.
- Avantax Advisory Services held 2,498 shares of Biogen worth $314K as of Q2 2025.
- Biogen was a new Avantax Advisory Services position in Q2 2025.
- Biogen made up ﹤0.01% of Avantax Advisory Services's portfolio in Q2 2025, its #1875 holding.
- Avantax Advisory Services first reported a position in Biogen in Q1 2020 and has held it in 13 quarters since.
- Avantax Advisory Services's Biogen position peaked at $617K in Q3 2021.
- 866 funds tracked by Wall St. Rank held Biogen as of Q2 2025.
Based on Avantax Advisory Services's 13F filing for Q2 2025, filed 8 Aug 2025.